SME Times is powered by   
Search News
Just in:   • Equity indices break two-day losing streak on value buying  • IMF urges Sri Lanka to tighten monetary policy  • Global semiconductor sales to reach $676 bn this year: Gartner  • Tinna Rubber hits upper circuit, investors accumulate 900% returns in year  • Availability of jobs in Japan improves for 1st time in 3 yrs 
Last updated: 27 Sep, 2014  

Indian Doctor Addresses World Cardiology Conference in Australia

PR Newswire | 09 May, 2014
MUMBAI and MELBOURNE: Dr. Rohit Sane of Sane Care's Madhavbaug clinics presented his pioneering research on a novel non-invasive herbal procedure Sampurna Hriday Shuddhikaran (SHS) in patients with Ischemic Heart Disease at World Cardiology Conference (4th - 7th May, 2014) in Melbourne, Australia. The study shows a marked improvement in exercise capacity and reduction in angina pain in patients who underwent SHS, a 6-day residential therapy.

India was estimated to account for almost 60% of the world's heart disease by 2010.1 By 2015, the number of patients with coronary heart disease is projected to be over 60 million.2 This places an inordinate amount of stress on the existing infrastructure to combat these diseases. Lack of access to the standard modern medicine treatments, their high prices and the risk of invasive procedures can deter people from getting them done.3 A possible answer to this problem can be novel, non-invasive and affordable therapies like SHS.

According to the ICMR Guidelines for Biomedical research, traditional knowledge systems like Ayurveda can prove to be a 'hidden treasure' if proven effective with modern scientific methods.4 However, reviewing the clinical researches in herbal treatment are found intertwined with huge difficulties primarily because of unavailability of published qualitative research work which is accessible.5

Dr. Sane has devised his own unique programme for treating heart diseases by creating an amalgam of Ayurveda and modern systems of medicine. Dr. Sane says, "Sampurna Hriday Shuddhikaran is a process we have created through our skill sets, using the science of pathophysiology of heart disease and procedures which might help heart disease." He explains that the SHS therapy works by improving circulation, reducing water retention, relaxing the muscles around the heart and improving its ability of contraction. As the study shows, testing SHS, amongst the parameters of modern scientific research has proven that this therapy is effective. It has the additional advantage of being cost-effective.

Dr. Dinesh Patil, a consulting cardiologist at Madhavbaug, reiterates the benefit of SHS, "I believe Ayurveda has a lot to offer to the modern practice of medicine. At Madhavbaug, Dr. Sane is continuously striving to validate these offerings and see if they stand the test of clinical trials. It is heartening to see these treatments work."

About the World Cardiology Conference:

Organised by the World Heart Federation, the conference is a global platform for cardiovascular disease specialists and public health professionals. The World Cardiology Conference 2014 hosted 150 sessions on cardiology, policy and public health by world's leading experts. Latest scientific findings are featured in over 1,000 new abstracts on prevention, diagnosis and treatment of cardiovascular disease.

About Dr. Rohit Sane and Madhavbaug:

Dr. Rohit Sane, the managing director of Sane Care group has developed the patented therapy SHS for cardiac diseases. He holds an MBBS degree from Aurangabad University, is an ex-fellow of Royal Society of Health (UK) and an MD in Alternative Medicine (USA). He has published his research in prominent journals like Lancet and presented it in multiple cardiology conferences all over the world. He is the key founder of Madhavbaug, the world's first ISO certified Ayurvedic cardiac care hospital in Khopoli. Madhavbaug has one of the largest chains of Cardiac care clinics with 175 clinics and 3 major hospitals spread over Maharashtra, Indore, Goa and London. More than 50,000 cardiac patients have received treatment at these centers. For more information, visit and Find us on Facebook:


    Xavier, et al. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet. 2008 Apr. 26;371(9622):1435-42.
    Karthikeyan, et al. Perspectives on the management of coronary artery disease in India. Heart. 2007 Nov;93(11): 1334-1338.
    Cardiovascular diseases in India Challenges and way ahead. International Heart Protection Summit. Sept 2011. Deloitte, ASSOCHAM [Internet]. [cited 2014 May 07]. Available from:
    Ethical Guidelines For Biomedical Research On Human Participants. Indian Council Of Medical Research, New Delhi. 2006.
    Sane R, et al. Effect of the Sampurna Hriday Shuddhikaran (SHS) Model in Heart Failure Patients in India: A Prospective Study. British Journal of Medicine & Medical Research. 2014;4(1):564-571.

Media Contact: Radhika Iyer,, 9221502555, Medulla Communications Pvt. Ltd.

Print the Page Add to Favorite
Share this on :

Please comment on this story:
Subject :
(Maximum 1500 characters)  Characters left 1500
Your name:

  Customs Exchange Rates
Currency Import Export
US Dollar
UK Pound
Japanese Yen 58.85 56.85
As on 27 Apr, 2022
  Daily Poll
COVID-19 has directly affected your business
 Can't say
  Commented Stories
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter